急性肾损伤

Kidney disease: improving global outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 Mar;2(1):1-138.全文

National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management. December 2019 [internet publication].全文

Kanagasundaram S, Ashley C, Bhojani S, et al. Renal Association clinical practice guideline acute kidney injury (AKI). August 2019 [internet publication].全文

Royal College of Physicians. Acute care toolkit 12: acute kidney injury and intravenous fluid therapy. October 2015 [internet publication].全文

1. Kidney disease: improving global outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012 Mar;2(1):1-138.全文

2. Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013 May;61(5):649-72.全文  摘要

3. National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management. December 2019 [internet publication].全文

4. Thomas ME, Blaine C, Dawnay A, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015 Jan;87(1):62-73. 摘要

5. Sharfuddin AA,  Weisbord SD,  Palevsky PM, et al. Acute kidney injury. In: Taal MW, Chertow GM, Marsden PA, et al, eds. Brenner and Rector's the kidney. 9th ed. Philadelphia, PA: Saunders; 2012.

6. Centers for Disease Control and Prevention (CDC). Hospitalization discharge diagnoses for kidney disease: United States, 1980-2005. MMWR Morb Mortal Wkly Rep. 2008 Mar 28;57(12):309-12. 摘要

7. Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007 Apr;18(4):1292-8.全文  摘要

8. Think Kidneys. Reporting the rate of acute kidney injury (AKI) within England – the current state of the NHS AKI Master Patient Index and Registry. January 2018 [internet publication].全文

9. Think Kidneys. Acute kidney injury best practice guidance: responding to AKI warning stage test results for adults in primary care. April 2016 [internet publication].全文

10. Selby NM, Kolhe NV, McIntyre CW, et al. Defining the cause of death in hospitalised patients with acute kidney injury. PLoS One. 2012 Nov 2;7(11):e48580.全文  摘要

11. Case J, Khan S, Khalid R, et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730.全文  摘要

12. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019 Nov 23;394(10212):1949-64. 摘要

13. Kanagasundaram S, Ashley C, Bhojani S, et al. Renal Association clinical practice guideline acute kidney injury (AKI). August 2019 [internet publication].全文

14. Hsu CY, McCulloch CE, Fan D, et al. Community-based incidence of acute renal failure. Kidney Int. 2007 Jul;72(2):208-12.全文  摘要

15. Ohnuma T, Uchino S, Toki N, et al. External validation for acute kidney injury severity scores: a multicenter retrospective study in 14 Japanese ICUs. Am J Nephrol. 2015;42(1):57-64. 摘要

16. Poukkanen M, Vaara ST, Reinikainen M, et al. Predicting one-year mortality of critically ill patients with early acute kidney injury: data from the prospective multicenter FINNAKI study. Crit Care. 2015 Mar 27;19:125.全文  摘要

17. Mehta R, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004 Oct;66(4):1613-21. 摘要

18. Liaño F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996 Sep;50(3):811-8. 摘要

19. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002 May 14;105(19):2259-64.全文  摘要

20. Liangos O, Wald R, O'Bell JW, et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006 Jan;1(1):43-51.全文  摘要

21. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005 Jan 29-Feb 4;365(9457):417-30. 摘要

22. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med. 1986 Jan 9;314(2):97-105. 摘要

23. Brezis M, Rosen S, Silva P, et al. Renal ischemia: a new perspective. Kidney Int. 1984 Oct;26(4):375-83. 摘要

24. Kaushal GP, Basnakian AG, Shah SV. Apoptotic pathways in ischemic acute renal failure. Kidney Int. 2004 Aug;66(2):500-6. 摘要

25. Zhou W, Farrar CA, Abe K, et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest. 2000 May;105(10):1363-71.全文  摘要

26. Thurman J, Lucia MS, Ljubanovic D, et al. Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int. 2005 Feb;67(2):524-30. 摘要

27. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 2004 Aug;66(2):480-5. 摘要

28. Lien YH, Yong KC, Cho C, et al. S1P(1) selective agonist, SEW2871, ameliorates ischemic-reperfusion injury in acute renal failure. Kidney Int. 2006 May;69(9):1601-8. 摘要

29. Boffa JJ, Arendshorst WJ, et al. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol. 2005 Jan;16(1):117-24. 摘要

30. Boffa JJ, Just A, Coffman TM, et al. Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol. 2004 Sep;15(9):2358-65. 摘要

31. Khan RZ, Badr KF. Endotoxin and renal function: perspectives to the understanding of septic acute renal failure and toxic shock. Nephrol Dial Transplant. 1999 Apr;14(4):814-8. 摘要

32. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004 Jul 8;351(2):159-69. 摘要

33. Badr KF, Kelley VE, Rennke HG, et al. Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int. 1986 Oct;30(4):474-80. 摘要

34. Weisberg LS, Kurnik PB, Kurnik BR, et al. Radiocontrast induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int. 1992 May;41(5):1408-15. 摘要

35. Russo D, Minutolo R, Cianciaruso B, et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol. 1995 Nov;6(5):1451-8. 摘要

36. Persson P, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005 Jul;68(1):14-22. 摘要

37. Cantley LG, Spokes K, Clark B, et al. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int. 1993 Dec;44(6):1217-23. 摘要

38. Heyman S, Rosenberger C, Rosen S, et al. Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant. 2005 Feb;20 Suppl 1:i6-11. 摘要

39. Pflueger A, Larson TS, Nath KA, et al. Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus. Mayo Clin Proc. 2000 Dec;75(12):1275-83. 摘要

40. Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol. 2017 Feb;28(2):653-9.全文  摘要

41. Brinjikji W, Demchuk AM, Murad MH, et al. Neurons over nephrons: systematic review and meta-analysis of contrast-induced nephropathy in patients with acute stroke. Stroke. 2017 Jul;48(7):1862-8.全文  摘要

42. Ehrmann S, Quartin A, Hobbs BP, et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. 2017 Jun;43(6):785-94. 摘要

43. Schreiner GF, Kohan DE. Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes. Am J Kidney Dis. 1990 Apr;258(4 Pt 2):F761-7. 摘要

44. Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis. 1991 Dec;18(6):689-99. 摘要

45. Ophascharoensuk V, Giachelli CM, Gordon K, et al. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 1999 Aug;56(2):571-80. 摘要

46. Moon JA, Kim HT, Cho IS, et al. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int. 2006 Oct;70(7):1234-43. 摘要

47. Lu JC, Coca SG, Patel UD, et al. Searching for genes that matter in acute kidney injury: a systematic review. Clin J Am Soc Nephrol. 2009 Jun;4(6):1020-31.全文  摘要

48. Zhao B. Genome-wide association study to identify single nucleotide polymorphisms conferring risk for acute kidney injury. Abstract TH-OR028. Paper presented at: Kidney Week 2014. 11-16 Nov 2014. Philadelphia, PA. J Am Soc Nephrol. 2014;25(suppl):7A.全文

49. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989 Jan 19;320(3):143-9. 摘要

50. Giuliano CA, Patel CR, Kale-Pradhan PB. Is the combination of piperacillin-tazobactam and vancomycin associated with development of acute kidney injury? A meta-analysis. Pharmacotherapy. 2016 Dec;36(12):1217-28. 摘要

51. Luther MK, Timbrook TT, Caffrey AR, et al. Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systematic review and meta-analysis. Crit Care Med. 2018 Jan;46(1):12-20. 摘要

52. Garg AX, Devereaux PJ, Yusuf S, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA. 2014 Jun 4;311(21):2191-8.全文  摘要

53. McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology. 1992 May;183(2):519-21. 摘要

54. Bell S, Dekker FW, Vadiveloo T, et al. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery - development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015 Nov 11;351:h5639.全文  摘要

55. Yang Y, George KC, Shang WF, et al. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Drug Des Devel Ther. 2017 Apr 24;11:1291-9.全文  摘要

56. Brown AC. Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series. Food Chem Toxicol. 2017 Sep;107(pt a):502-19. 摘要

57. Barrett BJ, Parfey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006 Jan 26;354(4):379-86. 摘要

58. Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017 Apr 1;389(10076):1312-22. 摘要

59. Weisbord SD, Gallagher M, Jneid H, et al; PRESERVE Trial Group. Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med. 2018 Feb 15;378(7):603-14.全文  摘要

60. Anderson SM, Park ZH, Patel RV. Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy. Ann Pharmacother. 2011 Jan;45(1):101-7. 摘要

61. Mei M, Zhao HW, Pan QG, et al. Efficacy of N-acetylcysteine in preventing acute kidney injury after cardiac surgery: a meta-analysis study. J Invest Surg. 2018 Feb;31(1):14-23. 摘要

62. Royal College of Physicians. Acute care toolkit 12: acute kidney injury and intravenous fluid therapy. October 2015 [internet publication].全文

63. Intensive Care Society. Standards and recommendations for the provision of renal replacement therapy on intensive care units in the United Kingdom. 2009.

64. Think Kidneys. Recommended minimum requirements of a care bundle for patients with AKI in hospital. December 2015 [internet publication].全文

65. Anathhanam S, Lewington AJ. Acute kidney injury. J R Coll Physicians Edinb. 2013;43(4):323-8; quiz 329. 摘要

66. Sawhney S, Mitchell M, Marks A, et al. Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open. 2015 Jan 6;5(1):e006497.全文  摘要

67. National Confidential Enquiry into Patient Outcome and Death. Adding insult to injury: a review of care of patients who died in hospital with a primary diagnosis of acute kidney injury (acute renal failure). 2009 [internet publication].全文

68. Baum N, Dichoso CC, Carlton CE. Blood urea nitrogen and serum creatinine. Physiology and interpretations. Urology. 1975 May;5(5):583-8. 摘要

69. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204-12.全文  摘要

70. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.全文  摘要

71. Levi TM, de Souza SP, de Magalhães JG, et al. Comparison of the RIFLE, AKIN and KDIGO criteria to predict mortality in critically ill patients. [in por]. Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):290-6.全文  摘要

72. Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006 Jul;34(7):1913-7. 摘要

73. Molitoris BA, Levin A, Warnock DG, et al. Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol. 2007 Aug;3(8):439-42. 摘要

74. Fujii T, Uchino S, Takinami M, et al. Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol. 2014 Feb 27;9(5):848-54.全文  摘要

75. Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009 Jun 23;35(10):1692-702. 摘要

76. Gabardi S, Munz K, Ulbricht C. A review of dietary supplement-induced renal dysfunction. Clin J Am Soc Nephrol. 2007 Jul;2(4):757-65.全文  摘要

77. Yarlagadda SG, Perazella MA. Drug-induced crystal nephropathy: an update. Expert Opin Drug Saf. 2008 Mar;7(2):147-58.全文  摘要

78. Feehally J, Gilmore I, Barasi S, et al. RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. J R Coll Physicians Edinb. 2013;43(1):37-8.全文  摘要

79. Academy of Medical Royal Colleges. Acute kidney injury: a competency framework. Defining the role of the expert clinician. November 2011 [internet publication].全文

80. UK Renal Association. Emergency management of hyperkalaemia in adults. March 2014 [internet publication].全文

81. Rahman M, Shad F, Smith MC. Acute kidney injury: a guide to diagnosis and management. Am Fam Physician. 2012 Oct 1;86(7):631-9. 摘要

82. Rachoin JS, Daher R, Moussallem C, et al. The fallacy of the BUN:creatinine ratio in critically ill patients. Nephrol Dial Transplant. 2011 Dec 29;27(6):2248-54.全文  摘要

83. Agrawal M, Swartz R. Acute renal failure. Am Fam Physician. 2000 Apr 1;61(7):2077-88. 摘要

84. Fogazzi GB. Crystalluria: a neglected aspect of urinary sediment analysis. Nephrol Dial Transplant. 1996 Feb;11(2):379-87. 摘要

85. Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol. 2013 Nov;8(11):1857-62.全文  摘要

86. Rossert J. Drug-induced acute interstitial nephritis. Kidney Int. 2001 Aug;60(2):804-17. 摘要

87. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 2002 Dec;62(6):2223-9.全文  摘要

88. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med 2018;56(12):2015-38. 摘要

89. Parikh CR, Lu JC, Coca SG, et al. Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise. Ann Clin Biochem. 2010 Jul;47(Pt 4):301-12. 摘要

90. Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008 May;73(9):1008-16. 摘要

91. Ho J, Tangri N, Komenda P, et al. Urinary, plasma, and serum biomarkers' utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis. Am J Kidney Dis. 2015 Dec;66(6):993-1005.全文  摘要

92. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463-93.全文  摘要

93. Zhang Z, Lu B, Sheng X, et al. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis. 2011 Sep;58(3):356-65. [Erratum in: Am J Kidney Dis. 2012 Apr;59(4):590-2.] 摘要

94. Small DM, Gobe GC. Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury. Expert Opin Drug Metab Toxicol. 2012 Jun;8(6):655-64. 摘要

95. Clerico A, Galli C, Fortunato A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med. 2012 Feb 15;50(9):1505-17. 摘要

96. Pappy R, Stavrakis S, Hennebry TA, et al. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol. 2011 Sep 15;151(3):348-53. 摘要

97. Royal College of Physicians of Edinburgh, NHS Kidney Care. Acute kidney injury. Mobile application content. February 2013 [internet publication].全文

98. Balasubramanian G, Al-Aly Z, Moiz A, et al. Early nephrologist involvement in hospital-acquired acute kidney injury: a pilot study. Am J Kidney Dis. 2011 Feb;57(2):228-34. 摘要

99. Wilson FP, Shashaty M, Testani J, et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet. 2015 May 16;385(9981):1966-74.全文  摘要

100. Meier P, Bonfils RM, Vogt B, et al. Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury. Clin J Am Soc Nephrol. 2011 Aug 4;6(9):2215-25.全文  摘要

101. Redl-Wenzl EM, Armbruster C, Edelmann G, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med. 1993;19(3):151-4. 摘要

102. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008 Feb 28;358(9):877-87.全文  摘要

103. Gordon AC, Russell JA, Walley KR, et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2009 Oct 20;36(1):83-91.全文  摘要

104. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010 Mar 4;362(9):779-89.全文  摘要

105. Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002 Nov 27;288(20):2547-53.全文  摘要

106. Cantarovich F, Rangoonwala B, Lorenz H, et al. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004 Sep;44(3):402-9. 摘要

107. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006 Jul 21;333(7565):420.全文  摘要

108. Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010 Jan 19;65(3):283-93.全文  摘要

109. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994 Nov 24;331(21):1416-20.全文  摘要

110. UK Renal Association. Clinical practice guidelines: treatment of acute hyperkalaemia in adults. March 2014 [internet publication].全文

111. National Institute for Health and Care Excellence. Eculizumab for treating atypical haemolytic uraemic syndrome. January 2015 [internet publication].全文

112. Matsumoto M, Fujimura Y, Wada H, et al. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Int J Hematol. 2017 May 26;106(1):3-15. 摘要

113. Joyce E, Glasner P, Ranganathan S, et al. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol. 2016 May 7;32(4):577-87. 摘要

114. National Institute for Health and Care Excellence. Renal replacement management therapy and conservative management. October 2018.全文

115. Lins RL, Elseviers MM, Van der Niepen P, et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant. 2008 Oct 14;24(2):512-8.全文  摘要

116. Palevsky PM, Zhang JH, O'Connor TZ, et al; VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008 Jul 3;359(1):7-20.全文  摘要

117. Tolwani AJ, Campbell RC, Stofan BS, et al. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008 Jun;19(6):1233-8.全文  摘要

118. Bellomo R, Cass A, Cole L, et al; RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009 Oct 22;361(17):1627-38.全文  摘要

119. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005 Nov;16(11):3365-70.全文  摘要

120. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000 Jul 1;356(9223):26-30.全文  摘要

121. Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006 Jul 19;70(7):1312-7.全文  摘要

122. Ronco C. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol. 1993 Oct;40(4):187-98. 摘要

123. Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003773.全文  摘要

124. Ponce D, Balbi AL. Peritoneal dialysis in acute kidney injury: a viable alternative. Perit Dial Int. 2011 Jul-Aug;31(4):387-9. 摘要

125. Ponce D, Berbel MN, Regina de Goes C, et al. High-volume peritoneal dialysis in acute kidney injury: indications and limitations. Clin J Am Soc Nephrol. 2012 Jun;7(6):887-94. 摘要

126. Phu NH, Hien TT, Mai NT, et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med. 2002 Sep 19;347(12):895-902.全文  摘要

127. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007798.全文  摘要

128. Royal College of Nursing. Catheter care: RCN guidance for health care professionals. Jul 2021 [internet publication].全文

129. Royal College of Nursing. Catheter care: guidance for health care professionals. Jul 2021 [internet publication].全文

130. Zhang T, Shen LH, Hu LH, et al. Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Nephrol. 2011;33(4):344-51.全文  摘要

131. Zhang BC, Li WM, Xu YW. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis. Can J Cardiol. 2011 Nov-Dec;27(6):851-8. 摘要

132. Giacoppo D, Capodanno D, Capranzano P, et al. Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization. Am J Cardiol. 2014 Aug 15;114(4):541-8. 摘要

133. Gandhi S, Mosleh W, Abdel-Qadir H, et al. Statins and contrast-induced acute kidney injury with coronary angiography. Am J Med. 2014 Oct;127(10):987-1000. 摘要

134. Bangalore S, Fayyad R, Hovingh GK, et al. Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials. Am J Cardiol. 2014 Jun 15;113(12):2018-20. 摘要

135. Susantitaphong P, Alfayez M, Cohen-Bucay A, et al. Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Resuscitation. 2012 Feb;83(2):159-67.全文  摘要

136. Pickkers P, Heemskerk S, Schouten J, et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial. Crit Care. 2012 Jan 23;16(1):R14.全文  摘要

137. Kim JE, Song SW, Kim JY, et al. Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest. Ann Thorac Surg. 2016 Feb;101(2):690-6. 摘要

138. Nigwekar SU, Strippoli GF, Navaneethan SD. Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD006740.全文  摘要

139. Yang Y, Lang XB, Zhang P, et al. Remote ischemic preconditioning for prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014 Oct;64(4):574-83. 摘要

140. Menting TP, Wever KE, Ozdemir-van Brunschot DMD, et al. Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury. Cochrane Database Sys Rev. 2017 Mar 4;(3):CD010777.全文  摘要

141. Moore PK, Hsu RK, Liu KD. Management of acute kidney injury: core curriculum 2018. Am J Kidney Dis. 2018 Feb 22;72(1):136-48.全文  摘要

142. Lewington AJ, Cerdá J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013 Sep;84(3):457-67.全文  摘要

143. Wang HE, Muntner P, Chertow GM, et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35(4):349-55.全文  摘要

144. Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: systematic review and meta-analysis. Am J Kidney Dis. 2009 Jun;53(6):961-73.全文  摘要

145. Tao Li PK, Burdmann EA, Mehta RL. Acute kidney injury: global health alert. Int J Organ Transplant Med. 2013;4(1):1-8.全文  摘要

146. Rimes-Stigare C, Awad A, Mårtensson J, et al. Long-term outcome after acute renal replacement therapy: a narrative review. Acta Anaesthesiol Scand. 2012 Feb;56(2):138-46. 摘要

147. Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM. 1996 Jun;89(6):415-21. 摘要

148. Rifkin DE, Coca SG, Kalantar-Zadeh K. Does AKI Truly Lead to CKD? J Am Soc Nephrol. 2012 Jun;23(6):979-84. 摘要

149. Leung KC, Tonelli M, James MT. Chronic kidney disease following acute kidney injury: risk and outcomes. Nat Rev Nephrol. 2013 Feb;9(2):77-85. 摘要

150. Bucaloiu ID, Kirchner HL, Norfolk ER, et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012 Mar;81(5):477-85. 摘要

151. Jaber S, Paugam C, Futier E, et al; BICAR-ICU Study Group. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet. 2018 Jul 7;392(10141):31-40. 摘要

152. Finn W. Recovery from acute renal failure. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st ed. Philadelphia, PA: WB Saunders; 2001:425-50.

153. Shaw NJ, Brocklebank JT, Dickinson DF, et al. Long-term outcome for children with acute renal failure following cardiac surgery. Int J Cardiol. 1991 May;31(2):161-5. 摘要

154. Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017 Jan;28(1):377-87.全文  摘要

155. Cerdá J, Liu KD, Cruz DN, et al. Promoting kidney function recovery in patients with AKI requiring RRT. Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1859-67. 摘要

156. Kidney Disease: Improving Global Outcomes (KDIGO). 2012 clinical practice guideline for the evaluation and management of chronic kidney disease (CKD). Kidney Int Suppl. 2013 Jan;3(1):1-150.全文

157. National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. Clinical guideline CG174. May 2017 [internet publication]全文

158. Verbrugge FH, Grieten L, Mullens W. Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med. 2014 Dec;4(3-4):176-88全文  摘要

159. Clark AL, Kalra PR, Petrie MC, et al. Change in renal function associated with drug treatment in heart failure: national guidance. Heart. 2019 Jun;105(12):904-10 摘要

160. Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults. Mar 2023 [internet publication].全文

161. Joint British Diabetes Societies for Inpatient Care. The management of the hyperosmolar hyperglycaemic state (HHS) in adults. Feb 2022 [internet publication].全文

162. Chowdhury TA, Cheston H, Claydon A. Managing adults with diabetes in hospital during an acute illness. BMJ. 2017 Jun 22;357:j2551 摘要

163. Joint British Diabetes Societies for Inpatient Care. Self-management of diabetes in hospital. Feb 2023 [internet publication].全文

164. Joint British Diabetes Societies for Inpatient Care. Glycaemic management during the inpatient enteral feeding of stroke patients with diabetes. Nov 2019 [internet publication].全文

165. Joint British Diabetes Societies for Inpatient Care. The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients. Oct 2014 [internet publication].全文

166. Joint British Diabetes Societies for Inpatient Care. A good inpatient diabetes service. Jul 2019 [internet publication].全文

167. Centre for Perioperative Care. Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery. Dec 2022 [internet publication].全文

168. Pasquel FJ, Lansang MC, Dhatariya K, et al. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021 Mar;9(3):174-88全文  摘要

169. Medicines and Healthcare products Regulatory Agency. SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness. March 2020 [internet publication]全文

170. Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015 Jun 15;38(9):1687-93 摘要

171. Fritz Z, Slowther AM, Perkins GD. Resuscitation policy should focus on the patient, not the decision. BMJ. 2017 Feb 28;356:j813全文  摘要

172. The National Institute for Health and Care Excellence. Decision making and mental capacity. October 2018 [internet publication]全文

173. Office of the Public Guardian. Mental Capacity Act: making decisions. Jun 2023 [internet publication]全文

174. Social Care Institute for Excellence. Independent mental capacity advocate (IMCA). January 2010 [internet publication]全文

175. ElSayed NA, Aleppo G, Aroda VR, et al, on behalf of the American Diabetes Association. 16. Diabetes care in the hospital: standards of care in diabetes - 2023. Diabetes Care. 2023 Jan 1;46(suppl 1):S267-78.全文  摘要

176. Joint British Diabetes Societies for Inpatient Care. A good inpatient diabetes service. Jul 2019 [internet publication].全文

177. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. Aug 2022 [internet publication].全文

178. Joint British Diabetes Societies for Inpatient Care. Inpatient care of the frail older adult with diabetes. Feb 2023 [internet publication].全文

179. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67全文  摘要

180. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97.全文  摘要

181. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest. 2010 Mar;137(3):544-51全文  摘要

182. Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations part 2: drug-Induced hyperglycemia. Diabetes Spect. 2011 Nov;24(4):234-8全文

183. NHS Digital. National Diabetes Inpatient Audit (NaDIA) - 2019. Nov 2020 [internet publication]全文

184. Joint British Diabetes Societies for Inpatient Care. The hospital management of hypoglycaemia in adults with diabetes mellitus. Jan 2023 [internet publication].全文

185. TREND Diabetes. End of life guidance for diabetes care. November 2021 [internet publication]全文

186. Grau AJ, Urbanek C, Palm F. Common infections and the risk of stroke. Nat Rev Neurol. 2010 Nov 9;6(12):681-94 摘要

187. Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000 Oct;31(10):2307-13 摘要

188. Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016 May 4;47(6):e98-e169全文  摘要

189. Pendlebury ST, Klaus SP, Mather M, et al. Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE. Age Ageing. 2015 Oct 13;44(6):1000-5全文  摘要

190. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233-8 摘要

191. National Institute for Health and Care Excellence. Delirium: prevention, diagnosis and management in hospital and long-term care. Jan 2023 [internet publication].全文

192. National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. Jun 2018 [internet publication].全文

193. Scottish Intercollegiate Guidelines Network. Risk reduction and management of delirium. Mar 2019 [internet publication].全文

194. Nova Scotia Health Authority. This is not my Mom. 2012 [internet publication]全文

195. Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med. 1999 May;106(5):565-73 摘要

196. Bellelli G, Morandi A, Davis DH, et al. Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. Age Ageing. 2014 Mar 2;43(4):496-502.全文  摘要

197. MacLullich AM, Shenkin SD, Goodacre S, et al. The 4 'A's test for detecting delirium in acute medical patients: a diagnostic accuracy study. Health Technol Assess. 2019 Aug;23(40):1-194全文  摘要

198. White S, Griffiths R, Baxter M, et al. Guidelines for the peri-operative care of people with dementia: guidelines from the Association of Anaesthetists. Anaesthesia. 2019 Jan 11;74(3):357-72全文  摘要

199. Siddiqi N, Harrison JK, Clegg A, et al. Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2016 Mar 11;3:CD005563全文  摘要

200. Martinez F, Tobar C, Hill N. Preventing delirium: should non-pharmacological, multicomponent interventions be used? A systematic review and meta-analysis of the literature. Age Ageing. 2014 Nov 25;44(2):196-204全文  摘要

201. Public Health England. Urinary tract infection: diagnostic tools for primary care. October 2020 [internet publication]全文

202. Medicines and Healthcare products Regulatory Agency. Haloperidol (haldol): reminder of risks when used in elderly patients for the acute treatment of delirium. 2021 [internet publication]全文

203. Ma H, Huang Y, Cong Z, et al. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. J Alzheimers Dis. 2014;42(3):915-37 摘要

204. Huybrechts KF, Gerhard T, Crystal S, et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ. 2012 Feb 23;344:e977全文  摘要

205. Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018 Mar 30;3:CD007726.全文  摘要

206. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13 摘要

207. Boden JM, Fergusson DM. Alcohol and depression. Addiction. 2011 May;106(5):906-14. 摘要

208. National Institute for Health and Care Excellence. Liaison psychiatry. In: Emergency acute medical care in over 16s: service delivery and organisation. March 2018 [internet publication]全文

209. National Confidential Enquiry into Patient Outcome and Death (NCEPOD). Treat as one. Bridging the gap between mental and physical healthcare in general hospitals. 2017 [internet publication]全文

210. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000 Jul 24;160(14):2101-7 摘要

211. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009 Apr 6;190(S7):S54-60 摘要

212. National Institute for Health and Care Excellence. Depression in adults with a chronic physical health problem: recognition and management. October 2009 [internet publication]全文

213. Prina AM, Cosco TD, Dening T, et al. The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: a systematic review. J Psychosom Res. 2015 Jan;78(1):25-33全文  摘要

214. Archer G, Kuh D, Hotopf M, et al. Association between lifetime affective symptoms and premature mortality. JAMA Psychiatry. 2020 Aug 1;77(8):806-13全文  摘要

215. Machado MO, Veronese N, Sanches M, et al. The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2018 Jul 20;16(1):112全文  摘要

216. Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015 May 12;29(5):459-525全文  摘要

217. Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 14th edition. Chichester: Wiley-Blackwell; 2021

218. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17;352(11):1112-20 摘要

219. Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014 Feb 19;348:g1626 摘要

220. Dalton SO, Sørensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs. 2006;20(2):143-51 摘要

221. Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003 Jan 13;163(1):59-64全文  摘要

222. Cheng YL, Hu HY, Lin XH, et al. Use of SSRI, but not SNRI, increased upper and lower gastrointestinal bleeding: a nationwide population-based cohort study in Taiwan. Medicine (Baltimore). 2015 Nov;94(46):e2022全文  摘要

223. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008 Jan 1;27(1):31-40全文  摘要

224. Flowers L. Nicotine replacement therapy. Am J Psychiatry Resid. 2016 Jun;11(6)4-7全文

225. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15(6):469-94 摘要

226. Oliveira P, Ribeiro J, Donato H, Madeira N. Smoking and antidepressants pharmacokinetics: a systematic review. Ann Gen Psychiatry. 2017;16:17全文  摘要

227. National Centre for Smoking Cessation and Training. Smoking cessation and mental health. 2014 [internet publication]全文

228. Roose SP, Rutherford BR. Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature. J Clin Psychopharmacol. 2016 Dec;36(6):704-9 摘要

229. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. July 2019 [internet publication].全文

230. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2023 [internet publication]全文

231. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004 Jun;125(6):2309-21全文  摘要

232. Au DH, Curtis JR, Every NR, et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest. 2002 Mar;121(3):846-51全文  摘要

233. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2023 [internet publication]全文

234. Walters JA, Tan DJ, White CJ, et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2018 Mar 19;3:CD006897全文  摘要

235. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. July 2019 [internet publication]全文

236. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. October 2019 [internet publication]全文

237. Rayman G, Vas PR, Baker N, et al. The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care. 2011 May 18;34(7):1517-8全文  摘要

238. National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence. Jan 2023 [internet publication].全文

239. Theodoulou A, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308全文  摘要

240. Rigotti NA, Kruse GR, Livingstone-Banks J, et al. Treatment of tobacco smoking: a review. JAMA. 2022 Feb 8;327(6):566-77.全文  摘要

241. Thomas KH, Dalili MN, López-López JA, et al. Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials. Addiction. 2022 Apr;117(4):861-76.全文  摘要

242. Livingstone-Banks J, Fanshawe TR, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 June 28;6(6):CD006103全文

243. Royal College of Physicians. National early warning score (NEWS2). Standardising the assessment of acute-illness severity in the NHS. December 2017 [internet publication]全文

244. O'Driscoll BR, Howard LS, Earis J, et al. BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax. 2017 Jun;72(suppl 1):ii1-90全文  摘要

245. Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): systematic review and meta-analysis. Lancet. 2018 Apr 26;391(10131):1693-705 摘要

246. Siemieniuk RAC, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline. BMJ. 2018 Oct 24;363:k4169. 摘要